Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Evinature is leading cutting-edge research in integrative therapies for irritable bowel syndrome (IBD). The company sources, develops, and distributes clinically proven nutraceuticals, providing patients around the world with access to accurate diagnosis and treatment through its proprietary online platform.
The Evinature platform guides patients through the CurQD Protocol, natural, tailored treatment regimes. The CurQD Protocol has been successfully implemented into standard clinical practice in medical centers in Israel.
North America, Israel, Bahamas, Bosnia and Herzegovina, Poland, Kuwait, Hong Kong, South Africa, Western Europe, Australia, Turkey, Singapore, Honduras, Cyprus, Colombia, United Arab Emirates, New Zealand, South Korea, Romania